Laboratory News and Research

RSS

Persistent Ebola virus can hide in the brain and re-emerge to cause fatal disease

In a groundbreaking study published today, scientists describe how Ebola virus, which can persist in certain areas of the body, can re-emerge to cause fatal disease-; even long after treatment with monoclonal antibodies.

9 Feb 2022

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

The novel coronavirus, or SARS-CoV-2, which causes the highly contagious COVID-19, has infected millions of people worldwide.

9 Feb 2022

UCLA researchers develop a smartwatch that assesses cortisol levels found in sweat

The human body responds to stress, from the everyday to the extreme, by producing a hormone called cortisol.

9 Feb 2022

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

Researchers investigated the dynamics and longevity of neutralizing antibody response up to 480 days after the onset of infection in convalescent COVID-19 patients.

9 Feb 2022

SPT Labtech paves the way for a new era of genomics liquid handling with firefly® launch

SPT Labtech today announced the launch of firefly®, an innovative liquid handling platform for next-generation sequencing (NGS) library preparation.

From SPT Labtech 9 Feb 2022

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury and the risk of blood clots in severe COVID-19 and other disorders that cause immune-mediated damage to the lungs, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.

8 Feb 2022

FDA-approved drug prevents the immune system from producing neutrophil extracellular traps

A team of scientists led by Cold Spring Harbor Laboratory (CSHL) have discovered that disulfiram, an FDA-approved drug, prevents the immune system from producing toxic webs known as neutrophil extracellular traps (NETs).

8 Feb 2022

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Mycology and immunology researchers from The University of Texas at San Antonio have been selected to receive a five-year, $6.8 million grant from the National Institutes of Health to establish a San Antonio-based Coccidioidomycosis Collaborative Research Center (SA-CCRC) focused on developing therapeutics and vaccines against coccidioidomycosis.

8 Feb 2022

Novel diagnostic platform offers hope for early detection of cancer in patients with Barrett’s esophagus

On a mission to increase early detection of esophageal cancer, University of Colorado (CU) Cancer Center member Sachin Wani, MD, is leading a study to see if a novel diagnostic platform can help endoscopists better identify the disease in patients with a condition called Barrett's esophagus.

8 Feb 2022

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

A new study examined the clinical manifestations of SARS-CoV-2 infections, disease severity, and related hospitalization in infants in Canada.

8 Feb 2022

Reanalysis of the efficacy of COVID-19 vaccines

In a new study, researchers investigated the impact of trial study design and other parameters on the estimates of COVID-19 vaccine efficacy.

8 Feb 2022

Research reveals a possible strategy to prevent B-cell acute lymphoblastic leukemia

Short-term treatment with the drug ruxolitinib prevents B-cell acute lymphoblastic leukemia (B-ALL) in mice that have a genetic predisposition to the disease.

8 Feb 2022

Dopamine signaling promotes the development of compulsive reward seeking behavior

Northwestern investigators have discovered that dopamine signaling in the brain's dorsomedial striatum promotes the development of compulsive behaviors in animal models, according to findings published in Current Biology.

7 Feb 2022

Colchicine holds promise to reduce the risk of severe COVID-19

A recent article, published in Rheumatology and Therapy, reviews the potent evidence of colchicine against the SARS-CoV-2 infection.

7 Feb 2022

First case of avian influenza A(H5N1) in asymptomatic flock owner in Europe

Following an outbreak of highly pathogenic avian influenza A(H5N1) in a flock of around 125 Muscovy ducks in a domestic setting in South West England on 22 December 2021, the virus was later also confirmed in the asymptomatic flock owner.

6 Feb 2022

Study finds increased vaccine breakthrough, less hospitalization rates and disease severity in omicron patients

Within only three weeks after the omicron variant was first identified among Houston Methodist patients, this variant rapidly took over and became the cause of a majority of new cases.

4 Feb 2022

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according to new research co-authored by researchers from Harvard T.H. Chan School of Public Health.

4 Feb 2022

Laboratory News and Research

Persistent Ebola virus can hide in the brain and re-emerge to cause fatal disease

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

UCLA researchers develop a smartwatch that assesses cortisol levels found in sweat

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

SPT Labtech paves the way for a new era of genomics liquid handling with firefly® launch

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

FDA-approved drug prevents the immune system from producing neutrophil extracellular traps

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Novel diagnostic platform offers hope for early detection of cancer in patients with Barrett’s esophagus

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

Reanalysis of the efficacy of COVID-19 vaccines

Research reveals a possible strategy to prevent B-cell acute lymphoblastic leukemia

Dopamine signaling promotes the development of compulsive reward seeking behavior

Colchicine holds promise to reduce the risk of severe COVID-19

First case of avian influenza A(H5N1) in asymptomatic flock owner in Europe

Study finds increased vaccine breakthrough, less hospitalization rates and disease severity in omicron patients

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

Developing injectable granular hydrogels for brain regeneration and function recovery after stroke

Researchers investigate how messenger substances signal inflammation during damaged cell removal

Gene therapy helps heart muscle cells electrically activate in live mice

Lab Diagnostics and Automation - Second Edition eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News